FeaturedNeurologyNeuroscienceOpen Neuroscience Articles·January 23, 2025·7 min readLong COVID Impairs Exercise Capacity and Cognition for YearsA study of nearly 1,000 people with post-COVID-19 syndrome (PCS) revealed that two-thirds still experienced significant symptoms, including reduced exercise capacity and cognitive performance, two years after infection. Persistent symptom clusters included fatigue, neurocognitive disturbances, and post-exertional malaise, with worse outcomes in individuals with obesity, lower education, or severe initial infections.Read More
FeaturedNeuroscience·January 6, 2025·5 min readExtended Paxlovid May Relieve Long Covid SymptomsExtended courses of Paxlovid may alleviate symptoms in some patients with long Covid, though its effectiveness varies widely. Of 13 patients studied, five experienced sustained improvements, while others reported temporary or no benefits.Read More
FeaturedNeurologyNeuroscience·December 4, 2024·6 min readMost Teens Recover From Long Covid Within Two YearsA large study tracking young people with long Covid found that 70% of those affected had recovered within two years, though 30% continued to experience symptoms. Researchers analyzed data from over 12,000 participants, defining long Covid as experiencing multiple symptoms like fatigue and headaches alongside functional impairments.Read More
FeaturedGeneticsNeurologyNeuroscience·November 29, 2024·5 min readSpike Protein Lingers in Brain, Fuels Long COVIDA new study reveals that the SARS-CoV-2 spike protein remains in brain-protective tissues and skull bone marrow for years after infection, potentially driving long COVID's neurological symptoms. Using advanced imaging, researchers discovered elevated spike protein levels in these regions, leading to chronic brain inflammation and increased risks of neurodegenerative conditions.Read More
FeaturedNeurologyNeuroscience·November 25, 2024·5 min readTENS Nerve Stimulation Ease Long Covid Pain and FatigueA new study demonstrates that a wearable Transcutaneous Electrical Nerve Stimulation (TENS) device can significantly reduce pain, fatigue, and mobility issues in people with long COVID. Participants using the active TENS device reported 26.1% greater pain relief and improved walking performance compared to a placebo group after four weeks of daily use.Read More
FeaturedNeurologyNeuroscience·November 9, 2024·6 min readAI Tool Reveals Long COVID May Affect 23% of PeopleA new AI tool identified long COVID in 22.8% of patients, a much higher rate than previously diagnosed. By analyzing extensive health records from nearly 300,000 patients, the algorithm identifies long COVID by distinguishing symptoms linked specifically to SARS-CoV-2 infection rather than pre-existing conditions. This AI approach, known as "precision phenotyping," helps clinicians differentiate long COVID symptoms from other health issues and may improve diagnostic accuracy by about 3%.Read More
FeaturedNeurologyNeuroscience·October 14, 2024·6 min readPersistent Virus May Drive Long COVIDA study found people with long COVID symptoms were twice as likely to have lingering SARS-CoV-2 proteins in their blood, suggesting a persistent viral reservoir may drive some ongoing symptoms. Researchers analyzed blood from 706 individuals and found that 43% of those with multisystem long COVID symptoms had viral proteins present months post-infection, compared to 21% of those without symptoms. This discovery hints at potential benefits from antiviral treatments for those with persistent symptoms. However, the study also reveals that not all long COVID cases show persistent viral proteins, indicating other causes may contribute to this complex condition.Read More
FeaturedNeurologyNeuroscience·October 8, 2024·5 min readBrainstem Inflammation Linked to Long-Covid SymptomsNew research shows that severe Covid-19 infection can cause inflammation in the brainstem, potentially leading to prolonged symptoms like fatigue, breathlessness, and anxiety. Using ultra-high-resolution 7-Tesla MRI scanners, scientists observed specific brainstem areas associated with these symptoms, highlighting how immune response post-infection might affect brain health.Read More
FeaturedNeurologyNeuroscience·October 6, 2024·5 min readStudy Finds Wegovy Reduces COVID-19 Death Risk by One-ThirdA new trial reveals that weekly injections of the weight-loss drug Wegovy (semaglutide) lowered the risk of death from COVID-19 by about a third and reduced overall mortality by 19%. The study followed more than 17,000 participants with heart disease and obesity, showing that Wegovy decreased the likelihood of death from cardiovascular disease by 15% and other causes by 23%.Read More
FeaturedNeurologyNeuroscience·October 4, 2024·6 min readCOVID-19 Affects Memory and Cognition for Up to a YearHealthy adults who contracted COVID-19 had subtle but measurable declines in memory and cognitive performance lasting up to a year. These differences were found through sensitive testing under controlled conditions, though all scores remained within normal ranges, and none of the participants reported lasting cognitive symptoms.Read More
FeaturedNeurologyNeuroscience·September 24, 2024·5 min readCognitive Impacts of COVID Equivalent to 20 Years of Brain AgingA new study reveals that 12-18 months after hospitalization for COVID-19, patients show significant cognitive decline comparable to 20 years of aging. MRI scans and blood tests also show brain injury markers and reduced brain volume in these patients. The findings suggest that COVID-19 has lasting effects on brain health, even in those without neurological complications.Read More
FeaturedNeuroscience·September 9, 2024·5 min readCOVID Pandemic Hastened Brain Aging in TeensThe COVID-19 pandemic accelerated brain maturation in adolescents, particularly girls, with their brains aging by an average of 4.2 years. The study links this acceleration to the stress of reduced social interaction during lockdowns, affecting brain regions responsible for emotional regulation.Read More
